PharmAbcine Company
PharmAbcine develops fully human therapeutic monoclonal antibodies for the treatment of cancer and inflammatory diseases.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Daejeon, Taejon-jikhalsi, South Korea
Founded Date:
2008
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Register and Claim Ownership